DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 127 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,422 | -47.1% | 158,713 | -33.6% | 0.07% | -42.7% |
| Q2 2023 | $2,690 | +21.7% | 239,072 | +24.6% | 0.12% | +12.5% |
| Q1 2023 | $2,210 | +24.1% | 191,872 | +24.9% | 0.10% | +5.1% |
| Q4 2022 | $1,781 | -99.9% | 153,645 | -0.9% | 0.10% | -16.8% |
| Q3 2022 | $1,970,000 | +1451.2% | 155,095 | +735.9% | 0.12% | +1090.0% |
| Q2 2022 | $127,000 | – | 18,555 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |